Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IPSC · as of Jun 9, 2026
Key Statistics
Explore Century Therapeutics, Inc. Data
ipsc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The IPSC analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +41.51% upside from the current price of $2.12.
Competitors & Peers
ipsc competitorsIPSC
COEP
CUE
EQ
GNTA
KPTIStock Performance
Full HistoryAbout Century Therapeutics, Inc.
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's for…
what is century therapeutics, inc. · ipsc stock overview · century therapeutics, inc. company profile · who is century therapeutics, inc. ceo · ipsc NASDAQ · century therapeutics, inc. headquarters · century therapeutics, inc. business segments
About Stock Overview & Key Data
Century Therapeutics, Inc. (IPSC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 18, 2021. As of the latest trading session, IPSC stock price is $2.12, with a market capitalization of $183.5M. The stock has returned +238.23% over the past 12 months and +113.11% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Century Therapeutics, Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Century Therapeutics, Inc. reported revenue of $109.2M and net income of -$9.6M. For detailed data — including Century Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Century Therapeutics, Inc. (IPSC) stock price is $2.12. The stock is traded on NASDAQ under the ticker symbol IPSC. The 52-week range is $0.43 – $3.04.